Last Updated : Friday, July 3, 2020 17:06:02

News of Central Gujarat in Gujarat

RIL’s JIO Platforms sells 0.39% stake to INTEL CAPITAL for 19 bln INR

MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Mukesh Ambani led Diversified Indian Conglomerate Reliance Group’s flagship company Reliance Industries Ltd said of Intel Capital, investment arm of Intel Corporation having invested 19 billion (~1,894.50 crore) rupees in Jio Platforms inturn acquiring 0.39% equity stake in the Jio

CADILA HEALTH gets DCGI-CDSCO nod for COVID19 vaccine’s human trials

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Pankaj Patel led healthcare service provider and pharmaceutical & wellness products manufacturing Zydus Group’s flagship company Cadila Healthcare Ltd claimed of having successfully completed preclinical development of the company’s vaccine for COVID19 – ZyCoV-D and having received permission

TCS and CELONIS partner to help Enterprises adopt process mining

MUNICH / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Ratan Tata led Diversified Indian Conglomerate Tata Group’s Information Technology (IT) Consulting & Software services providing arm Tata Consultancy Services (TCS) Ltd said of having partnered with Munich (Germany) headquartered Celonis to help Enterprises adopt process mining to

TCS BaNCS™ Recognized as a Leader in Universal and Pureplay Digital Banking

LONDON / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ratan Tata led Diversified Indian Conglomerate Tata Group’s Information & Technology (IT) Consulting & Software services providing arm – Tata Consultancy Services (TCS) Ltd said of TCS BaNCS™ suite (software) having been recognized as a leader in the

ALEMBIC PHARMA gets USFDA nod to sell tablets to treat bacterial infections

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered pharmaceutical products manufacturing Indian company Alembic Pharmaceuticals Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell tablets to cure bacterial infections. In a press-release titled, “Alembic Pharmaceuticals receives USFDA

TCS leads IDC MarketScape for Digital Transformation Services for Oil & Gas

NEW YORK (US) / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Ratan Tata led Mumbai headquartered Diversified Indian Conglomerate – Tata Group’s Information Technology (IT) Consulting & Software Services providing arm Tata Consultancy Services (TCS) Ltd said of having been recognized as a leader in IDC Marketspace

ARVIND FASHIONS to raise 4 billion (~400 Cr) rupees via Rights Issue

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Ahmedabad headquartered textiles and apparels Indian major Arvind Ltd’s fashion arm Arvind Fashions Ltd said of its intent to raise 4 billion (~399.79 crore) rupees via Rights Issue. In a press-release titled, “Arvind Fashions Limited to raise up

Alembic JVC ALEOR DERMA gets USFDA nod to sell gel to treat pimples, cysts

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Amin family owned 100 years old pharmaceutical products manufacturing Indian company Alembic Pharmaceuticals Ltd said of having announced its joint-venture company Aleor Dermaceuticals having received USFDA (US Food & Drugs Administration) nod to sell

SAUDI ARABIAN money pours in RIL’s JIO, buys 2.32% stake paying 114 bln INR

MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Mukesh Dhirubhai Ambani led Diversified Indian Conglomerate – Reliance Group’s flagship company Reliance Industries Ltd said of public investment fund (PIF) having invested 113.67 billion (~11,367 crore) rupees in Jio Platforms Ltd acquiring 2.32% equity stake on fully diluted basis

TCS collaborates with IBM to power Digital & Cognitive Transformation

BENGALURU / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Ratan Tata led Diversified Indian Conglomerate – Tata Group’s Information Technology (IT) Consulting & Software services providing arm – Tata Consultancy Services (TCS) Ltd said of having collaborated with IBM to power digital and cognitive enterprise transformations with

CADILA HEALTH gets USFDA nod to sell medicine to treat blood disorders

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Pankaj Patel led healthcare services and pharma & wellness products manufacturing Zydus Group’s flagship company Cadila Healthcare Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell medicine to treat excess iron

ALEMBIC PHARMA gets USFDA nod to sell medicine to treat blood disorders

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara headquartered Amin family owned 100 years old pharmaceutical products manufacturing Indian company Alembic Pharmaceuticals Ltd said of having got a USFDA (US Food & Drugs Administration) nod to sell medicine to treat chronic iron overload in

TATA POWER bags 120 MW Power Project from GUJARAT Govt’s DisComm

GANDHINAGAR / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Mumbai headquartered Ratan Tata led Diversified Indian Conglomerate – Tata Group’s power arm Tata Power Company Ltd said of having bagged contract to develop 120 MW of Solar Power Project in the state of Gujarat, which has been

SUN PHARMA inks EXCL licensing & dist pact for medicine to treat psoriasis

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered pharmaceutical products manufacturing Indian company Sun Pharmaceutical Industries Ltd said of one of its subsidiaries having inked and entered into an exclusive agreement with London (UK) based Hikma Pharmaceuticals PLC for an exclusive licensing

TCS Crystallus™ Launched to Help Enterprises Accelerate ERP Transformations

MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Mumbai headquartered Ratan Tata lead Diversified Indian Conglomerate – Tata Group’s Information & Technology (IT) Consulting and Software services providing arm – Tata Consultancy Services (TCS) Ltd said of having launched TCS Crystallus™ to help enterprises accelerate SAP S/4 HANA

CADILA HEALTH ink pact with GILEAD SCIENCES to mfr & mkt REMDESIVIR

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges from Ahmedabad headquartered Pankaj Patel led Zydus Group’s Healthcare Services providing, Pharmaceutical and Wellness products manufacturing Indian company Cadila Healthcare Ltd it said of having inked non-exclusive licensing agreement with Gilead Sciences Inc., to manufacture and market Remdesivir

Do NOT follow this link or you will be banned from the site!